Report Overview

According to the deep-dive market assessment study by Growth Plus Reports, the global HbA1c Testing market was valued at US$ 1.3 billion in 2020 and is expected to register a revenue CAGR of 8.5% to reach US$ 3.17 billion by 2031.

HbA1c Testing Market Fundamentals

The HbA1c test is also known as the glycated hemoglobin or hemoglobin A1c test. Measuring glycated hemoglobin (HbA1c) gives an overall picture of the average blood sugar levels of an individual over the past three months. The test is used to detect diabetes or prediabetes in adults. High HbA1c levels can be a sign of diabetes, a chronic condition that can cause serious health issues, such as nerve damage, heart disease, and kidney disease. This test can also help in monitoring an individual’s glucose levels. A normal A1C level is below 5.7%.

[78789]

HbA1c Testing Market Dynamics

The global HbA1c testing market revenue growth is driven by rising prevalence of diabetes, increasing geriatric population, and growing awareness about the importance of diabetes management. Moreover, low cost of testing, technological advancements, and increase in launches of FDA-approved products are expected to propel revenue growth in the HbA1c testing market.

Genetic variants and modified derivatives of hemoglobin can affect the accuracy of HbA1c. Such factors are likely to hinder the adoption of HbA1c tests, which in turn, is expected to restrain sales growth in the global market during the forecast period.

HbA1c Testing Market Ecosystem

The global HbA1c testing market is analyzed based on four parameters: product, technology, end user, and region.

HbA1c Testing Market by Product

[9008]

Based on the product, the HbA1c testing market is segmented into instruments and consumables.

The instruments segment is sub-segmented into benchtop devices and handheld devices. The instruments segment accounts for the largest revenue share of the market. This can be ascribed to rising prevalence of diabetes and the ability of these instruments to provide faster and more accurate results.

HbA1c Testing Market by Technology

Based on the technology, the market is segmented into ion-exchange HPLC, boronate affinity chromatography, turbidimetric inhibition immunoassay, direct enzymatic assay, and other technologies. 

The ion-exchange HPLC segment accounts for the largest revenue share of the HbA1c testing market. This can be ascribed to increase in the usage of the technology owing to its advantages, such as higher accuracy, improved sensitivity, and cost-effectiveness.

HbA1c Testing Market by End User

Based on the end user, the market is segmented into hospitals & clinics, diagnostic laboratories, and home care. 

The home care segment is expected to be the fastest-growing segment during the forecast period. Rising awareness about and increasing adoption of diabetes self-management are expected to fuel revenue growth in this segment.

HbA1c Testing Market by Region

Based on the region, the global HbA1c testing market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). 

North America accounts for the largest revenue share of the global HbA1c testing market. This can be ascribed to rising geriatric diabetic population and growing need for continuous glucose level monitoring among diabetic patients. Moreover, presence of a significant number of laboratories providing HbA1c testing services and growing focus of prominent players toward launching products in this region are propelling the revenue growth of this market.

HbA1c Testing Market Competitive Landscape

The prominent players operating in the global HbA1c testing market include:

• Abbott
• Siemens Healthcare Private Limited
• Arkray, Inc.
• Bio-Rad Laboratories, Inc
• F. Hoffmann-La Roche Ltd.
• PTS Diagnostics
• Transasia Bio-Medicals
• Danaher
• Trinity Biotech
• Tosoh Corporation

Frequently Asked Questions About This Report